Educational Objectives
By the end of this course, you will be able to:
-
Identify the clinically relevant pharmacological characteristics of buprenorphine
-
Describe the resources needed to establish office-based treatment with buprenorphine for patients with opioid dependence
-
Distinguish between spontaneous and precipitated opioid withdrawal
-
Describe the functions of full opioid agonists, partial agonists, and antagonists
-
Describe several symptoms of opioid withdrawal or intoxication that mimic symptoms of a psychiatric disorder
-
List the criteria for establishing the diagnosis of opioid dependence
-
Describe a number of important factors to consider in determining whether a patient is an appropriate candidate for office-based buprenorphine treatment
-
List special treatment considerations associated with adolescent opioid-dependent patients
-
List key factors to consider in evaluating a pregnant, opioid-dependent woman
- Describe the essential areas that should be covered in the rules and expectations communicated to patients during the patient assessment process
-
Describe elements that must be part of the system for urine testing for the procedures to be clinically valid
-
List several situations in which patient information, with patient identity, can be shared under current laws protecting a patient's confidentiality.
|
